Slate Run Pharmaceuticals is recalling all unexpired lots of Eptifibatide Injection (75 mg/100 mL) because the carton incorrectly identifies the medication for 'bolus dosing' (a rapid, one-time dose). The approved use for this specific concentration is actually for a 'weight-adjusted infusion' (a slow, continuous drip). This labeling error could lead to dosing mistakes in a clinical setting.
If a healthcare provider follows the incorrect carton label, a patient could receive the wrong dose or administration rate of this blood-thinning medication, which may lead to treatment complications. No injuries or adverse events have been reported to date.
All lots within expiry are affected. Carton incorrectly states 'for weight-adjusted bolus dosing' instead of 'for weight-adjusted infusion'.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.